48 related articles for article (PubMed ID: 10645033)
1. [Bone turnover and bone density in type 1 diabetics in the initial stages of diabetic nephropathy].
Pontuch P; Payer J; Killinger Z; Toserova E; Listiakova D
Bratisl Lek Listy; 1999 Aug; 100(8):445-8. PubMed ID: 10645033
[TBL] [Abstract][Full Text] [Related]
2. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
Olmos JM; Pérez-Castrillón JL; García MT; Garrido JC; Amado JA; González-Macías J
Bone Miner; 1994 Jul; 26(1):1-8. PubMed ID: 7950501
[TBL] [Abstract][Full Text] [Related]
3. The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.
Chen H; Li X; Yue R; Ren X; Zhang X; Ni A
Diabetes Res Clin Pract; 2013 May; 100(2):272-6. PubMed ID: 23522918
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
5. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
7. [Change of bone mineral density in type 2 diabetes mellitus with nephropathy].
Lei MX; Liao L; Chen HL
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):477-9. PubMed ID: 12212125
[TBL] [Abstract][Full Text] [Related]
8. Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy.
Jensen T; Borch-Johnsen K; Deckert T
Diabetes Res; 1987 Apr; 4(4):159-62. PubMed ID: 3621799
[TBL] [Abstract][Full Text] [Related]
9. [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus].
Miazgowski T; Andrysiak-Mamos E; Pynka S; Gulińska M; Czekalski S
Przegl Lek; 1997; 54(7-8):533-9. PubMed ID: 9480464
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
11. [Diurnal changes in blood pressure, albuminuria and urinary excretion of retinol-binding protein in type I diabetics].
Pontuch P; Toserová E; Bulas J; Kratochvíl'ová H
Vnitr Lek; 1996 Jan; 42(1):3-6. PubMed ID: 8629357
[TBL] [Abstract][Full Text] [Related]
12. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus.
Lumachi F; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E64-7. PubMed ID: 19751417
[TBL] [Abstract][Full Text] [Related]
14. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.
Akin O; Göl K; Aktürk M; Erkaya S
Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015
[TBL] [Abstract][Full Text] [Related]
16. Bone remodeling and bone mineral density during pregnancy.
Ulrich U; Miller PB; Eyre DR; Chesnut CH; Schlebusch H; Soules MR
Arch Gynecol Obstet; 2003 Oct; 268(4):309-16. PubMed ID: 14504876
[TBL] [Abstract][Full Text] [Related]
17. A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus.
Miazgowski T; Czekalski S
Osteoporos Int; 1998; 8(5):399-403. PubMed ID: 9850345
[TBL] [Abstract][Full Text] [Related]
18. Increased blood pressure in diabetes: essential hypertension or diabetic nephropathy?
Christensen CK; Krusell LR; Mogensen CE
Scand J Clin Lab Invest; 1987 Jun; 47(4):363-70. PubMed ID: 3602914
[TBL] [Abstract][Full Text] [Related]
19. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
